Annie Lennon's profile photo

Annie Lennon

London

Writer at Freelance

Featured in: Favicon labroots.com Favicon medicalnewstoday.com Favicon psychologytoday.com Favicon flipboard.com Favicon psychcentral.com Favicon geneticliteracyproject.org Favicon healthgrades.com Favicon newsbreak.com Favicon southfloridareporter.com Favicon callandpost.com

Articles

  • 1 week ago | labroots.com | Annie Lennon

    Increasing physical activity between 45 and 65 years old may help prevent ALzheimer's disease (AD), found a new study published in Alzheimer's & Dementia. Around 13% of AD cases worldwide may be attributed to a lack of physical activity. Physical activity has meanwhile been linked to a decreased risk of cognitive decline and AD, especially in midlife.

  • 1 week ago | medscape.com | Annie Lennon

    Almost one in four adults in England have found inaccuracies or missing information in their medical records, new research has shown. The findings come from a nationally representative poll carried out by BMG Research on behalf of Healthwatch England in March this year. Researchers surveyed 1800 adults in England online. Of those, 23% reported errors in their records.

  • 1 week ago | labroots.com | Annie Lennon

    Patients hospitalized for heart failure who have cannabis use disorder (CUD) are significantly more likely to experience cardiogenic shock, acute myocardial infarction, and arrhythmias than those without the condition. The corresponding study was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.

  • 2 weeks ago | medscape.com | Annie Lennon

    Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a conditional marketing authorization for Duvyzat (givinostat, Italfarmaco) to treat Duchenne muscular dystrophy (DMD) in patients aged 6 years and older who can walk. Conditional marketing authorization is granted when the benefit of immediate availability outweighs the risk of less comprehensive data than normally required. The marketing authorization holder is to provide extra clinical data at a later stage.

  • 2 weeks ago | medscape.com | Annie Lennon

    The European Medicines Agency (EMA) has recommended marketing authorization for Tepezza (teprotumumab) for adults with moderate to severe thyroid eye disease (TED). TED is a rare autoimmune condition characterized by the inflammation of muscles, fat, and other tissues around and behind the eyes. Symptoms include eyeball protrusion from the eye socket, red and swollen eyelids, and double vision. In Europe, there are between 90 and 155 cases of TED per 100,000 persons.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →